Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Merck: La administración de Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S06Conocimiento y comunicaciónDesde 5,74 €
-
Brasil Foods (Spanish version)
Bell, David E.; Kindred, NatalieCaso HBS-514S04Dirección estratégicaA mediados de 2011, la gestión de Brasil Foods, un brasileño que lleva la marca de alimentos productor y exportador de proteínas, está evaluando estrategias para el crecimiento internacional y nacional. El equipo acaba de recibir la aprobación de las autoridades antimonopolio de Brasil para completar la fusión de Perdigao y Sadia, los dos productores de alimentos masivas que se habían combinado para formar Brasil Foods en 2009. Ahora, el equipo e...Desde 8,20 €
-
BRF (Spanish Version)
Bell, David E.; Kindred, NatalieCaso HBS-521S01MarketingIn 2015, BRF's new leadership team is transforming several aspects of the Brazilian protein giant, which had grown sluggish after the 2011 merger that created it. Underlying their reforms are the common goals of reducing bureaucracy, streamlining decision making, and, most importantly, creating a unified culture that, to date, the company has been missing. CEO Pedro Faria believes a strong culture, in which both BRF employees and its thousands of...Desde 8,20 €
-
Camposol (Spanish version)
Bell, David E.; Kindred, NatalieCaso HBS-518S10MarketingWith $289 million in 2015 revenues, Camposol is a Peruvian grower, exporter, and marketer of fruits and vegetables, with a focus on the high-growth, high-margin blueberry category. Camposol aspires to become Peru's first multinational branded produce company. It already has a strong foothold in the U.S.-an important market where it is refining its branding and retail-customer strategy-and it also seeks to expand in other markets, especially China...Desde 8,20 €
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCaso HBS-111S02Dirección estratégica(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Desde 8,20 €